October 1, 2019 (v1)
Journal article
BACKGROUND:This prospective multicenter study evaluated the prognostic value of circulating tumor cells (CTCs) in relapsing nonoperable or metastatic head and neck squamous cell carcinoma (rHNSCC) treated by chemotherapy and cetuximab.METHODS:In 65 patients suitable for analyses, peripheral blood was taken at day 0 (D0) D7, and D21 of treatment...
Uploaded on: December 4, 2022